Trending

Inventiva

Analysts tip Inventiva’s lanifibranor as NASH blockbuster

Analysts tip Inventiva’s lanifibranor as NASH blockbuster

Inventiva’s lanifibranor has been tipped to become a blockbuster in the fatty liver disease non-alcoholic steatohepatitis (NASH) after it became

X

Analysts tip Inventiva’s lanifibranor as NASH blockbuster

https://pharmaphorum.com/news/analyst-tip-inventivas-lanifibranor-as-nash-blockbuster-after-trial-win/

Boehringer to develop fibrosis treatment with Inventiva

Boehringer to develop fibrosis treatment with Inventiva

Boehringer to progress R&D partnership that began last year

X

Boehringer to develop fibrosis treatment with Inventiva

https://pharmaphorum.com/news/boehringer-takes-option-develop-fibrosis-inventiva/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com